DividendInvestor.com
First In Dividend Data Worldwide®
DIVIDEND ANNOUNCEMENT: Loncar Cancer Immunotherapy ETF/ETF Series Solutions (NASDAQ:CNCR) on 12/28/2021 declared a dividend of $1.8533 per share
Loncar Cancer Immunotherapy ETF/ETF Series Solutions (NASDAQ:CNCR) on 12/28/2021 declared a dividend of $ 1.8533 per share payable on December 31, 2021 to shareholders of record as of December 30, 2021. Dividend amount recorded is an increase of $ 1.5652 from last dividend Paid.
Loncar Cancer Immunotherapy ETF/ETF Series Solutions (NASDAQ:CNCR) has paid dividends since 2016, has a current dividend yield of 7.0867652893% and has increased its dividends for 0 successive years.
Loncar Cancer Immunotherapy ETF/ETF Series Solutions's market cap is $ 2,610,500 and has a PE ratio of 0.00. The stock price closed yesterday at $ 26.10 and has a 52 week low/high of $ 24.00 and $ 35.82.
For more information on Loncar Cancer Immunotherapy ETF/ETF Series Solutions click here.
Dividend Ex Date: December 29, 2021
Dividend Record Date: December 30, 2021
Dividend Payment Date: December 31, 2021
Dividend Amount: $ 1.8533
CNCR LINKS
CNCR Dividend History Detail
CNCR Projected 10 Year Dividend Yield
CNCR Dividend News
CNCR Competitors News
DividendInvestor.com
DividendInvestor.com is a leading worldwide independent provider of dividend information and data for investment professionals. Our mission is to be the First In Dividend Data Worldwide® by designing and developing essential tools and systems for the investment community with the highest level of accuracy and integrity.
Contact:
info@DividendInvestor.com